Publication Information

{'id': 'https://openalex.org/W155261174', 'doi': None, 'title': 'Эффективность антиэпилептических препаратов новой генерации в терапии криптогенных и симптоматических фокальных форм эпилепсии у детей', 'display_name': 'Эффективность антиэпилептических препаратов новой генерации в терапии криптогенных и симптоматических фокальных форм эпилепсии у детей', 'publication_year': 2013, 'publication_date': '2013-01-01', 'ids': {'openalex': 'https://openalex.org/W155261174', 'mag': '155261174'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://cyberleninka.ru/article/n/effektivnost-antiepilepticheskih-preparatov-novoy-generatsii-v-terapii-kriptogennyh-i-simptomaticheskih-fokalnyh-form-epilepsii-u', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210182057', 'display_name': 'The Bulletin of Contemporary Clinical Medicine', 'issn_l': '2071-0240', 'issn': ['2071-0240', '2079-553X'], 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5055111113', 'display_name': 'С Н Сивкова', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Светлана Николаевна Сивкова', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5075428154', 'display_name': 'Ф М Зайкова', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Фания Мансуровна Зайкова', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '6', 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10094', 'display_name': 'Epilepsy and Seizures', 'score': 0.9962, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10094', 'display_name': 'Epilepsy and Seizures', 'score': 0.9962, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12229', 'display_name': 'Prenatal Exposure to Antiepileptic Drugs', 'score': 0.9745, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T13561', 'display_name': 'Deuterium Incorporation in Pharmaceutical Research', 'score': 0.9731, 'subfield': {'id': 'https://openalex.org/subfields/3003', 'display_name': 'Pharmaceutical Science'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/antiepileptic-drugs', 'display_name': 'Antiepileptic Drugs', 'score': 0.569915}], 'concepts': [{'id': 'https://openalex.org/C2777683783', 'wikidata': 'https://www.wikidata.org/wiki/Q221174', 'display_name': 'Topiramate', 'level': 3, 'score': 0.9854692}, {'id': 'https://openalex.org/C2778802184', 'wikidata': 'https://www.wikidata.org/wiki/Q410346', 'display_name': 'Lamotrigine', 'level': 3, 'score': 0.96880317}, {'id': 'https://openalex.org/C2778186239', 'wikidata': 'https://www.wikidata.org/wiki/Q41571', 'display_name': 'Epilepsy', 'level': 2, 'score': 0.752001}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7005042}, {'id': 'https://openalex.org/C2775858608', 'wikidata': 'https://www.wikidata.org/wiki/Q576618', 'display_name': 'Anticonvulsant', 'level': 3, 'score': 0.61142635}, {'id': 'https://openalex.org/C42219234', 'wikidata': 'https://www.wikidata.org/wiki/Q131130', 'display_name': 'Anesthesia', 'level': 1, 'score': 0.4558926}, {'id': 'https://openalex.org/C187212893', 'wikidata': 'https://www.wikidata.org/wiki/Q123028', 'display_name': 'Pediatrics', 'level': 1, 'score': 0.43556762}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.09861308}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://cyberleninka.ru/article/n/effektivnost-antiepilepticheskih-preparatov-novoy-generatsii-v-terapii-kriptogennyh-i-simptomaticheskih-fokalnyh-form-epilepsii-u', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210182057', 'display_name': 'The Bulletin of Contemporary Clinical Medicine', 'issn_l': '2071-0240', 'issn': ['2071-0240', '2079-553X'], 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.7, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': [], 'abstract_inverted_index': {'Purpose.': [0], 'Comparison': [1], 'of': [2, 6, 9, 19, 25, 34, 59, 63, 90, 138, 144, 162, 168, 202], 'the': [3, 85, 91, 115], 'clinical': [4, 193], 'efficiency': [5, 194], 'antiepileptic': [7, 129], 'drugs': [8], 'new': [10], 'generation': [11], '—': [12, 16], 'topiramate': [13, 68, 157, 178], 'and': [14, 21, 30, 55, 124, 159, 179, 188, 198], 'lamotrigine': [15, 97, 165, 189], 'in': [17, 27, 38, 50, 69, 98, 122, 125, 136, 140, 152, 156, 160, 164, 173, 180, 195, 204], 'treatment': [18, 196], 'symptomatic': [20, 54, 197], 'cryptogenic': [22, 56, 199], 'focal': [23, 57, 200], 'forms': [24, 58, 201], 'epilepsy': [26, 203], 'children.': [28, 205], 'Material': [29], 'methods.': [31], '2': [32, 42, 181], 'groups': [33], 'patients': [35, 64, 139, 183], 'were': [36, 65], 'included': [37], 'research,': [39], 'aged': [40], 'from': [41, 71, 77, 100, 107], 'to': [43, 74, 81, 104, 111], '17': [44, 82], 'years': [45], 'old,': [46], 'on': [47], '31': [48], 'person': [49], 'each': [51, 141], 'group': [52, 62, 93, 158], 'with': [53, 127], 'epilepsy.': [60], '1': [61, 174], 'treated': [66], 'by': [67, 96], 'dozes': [70, 99], '56': [72], 'up': [73, 80, 103, 110], '500': [75], 'mg/day,': [76, 106], '2,8': [78], 'mg/kg/day': [79, 83, 109, 113], '(on': [84, 114], 'average': [86, 116], '6,6': [87], 'mg/kg/day).': [88], 'Patients': [89], 'second': [92], 'received': [94], 'therapy': [95], '25': [101], 'mg/day': [102], '250': [105], '0,5': [108], '6': [112], '3,6': [117], 'mg/': [118], 'kg/day).': [119], 'Treatment': [120], 'was': [121, 134, 150, 171], 'monotherapy': [123], 'combinations': [126], 'others': [128], 'grugs.': [130], 'Results.': [131], 'Seizures': [132], 'freedom': [133], 'achieved': [135], '26%': [137], 'groups.': [142], 'Reduction': [143], 'seizures': [145, 170], 'freqency': [146], 'more': [147], 'than': [148], '50%': [149], 'observed': [151], '61': [153], '%': [154], 'cases': [155, 163], '45%': [161], 'group.': [166], 'Aggravation': [167], 'myoclonic': [169], 'registered': [172], '(3%)': [175], 'patient,': [176], 'used': [177, 184], '(6%)': [182], 'lamotrigine.': [185], 'Conclusion.': [186], 'Topiramate': [187], 'have': [190], 'shown': [191], 'high': [192]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W155261174', 'counts_by_year': [], 'updated_date': '2024-09-16T06:50:40.623004', 'created_date': '2016-06-24'}